Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04690660

Swiss Postpartum Hypertension Cohort

Swiss Postpartum Hypertension Cohort (Swiss-PPHT)

Status
Recruiting
Phase
Study type
Observational
Enrollment
480 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This open label, prospective observational, single-center registry is to study short-, intermediate-and long-term course of postpartum hypertension and predictors/risk factors associated with long term cardiovascular and renal risk. Current disease management strategies will be evaluated.

Conditions

Interventions

TypeNameDescription
OTHERData collection for parameters of organ damage (cardiac and renal blood markers)Blood results will be taken out of next routine venipuncture. Routinely collected standard parameters are a blood count, chemistry panel including renal parameters and electrolytes, lipid profile and a HbA1c as well as albumin/creatinine and protein/creatinine ratio in urine.
OTHERData collection for blood pressure (BP)Clinic blood pressure and 24hour BP Measurements
OTHERHome-based blood pressure management (substudy)Subjects participating in home-based blood pressure management via telemonitoring will receive a free HekaHealth application (App) for the structured assessment of HBPM.
OTHERBiomarker Profiles (substudy)Substudy where possible cardiac, renal and pregnancy related biomarkers will be additionally analyzed. The following biomarkers will be analyzed: N terminal (NT)-proBNP, Troponin, elevated mid-regional pro-atrial natriuretic peptide (ANP), elevated mid-regional pro adrenomedullin (ADM), soluble fms-like tyrosine kinase (sFlt-1), and placenta growth factor (PlGF).
OTHERData collection on patient reported outcomesData collection on patient reported outcomes (Questionnaire EQ-5D, Questionnaire for App based monitoring )

Timeline

Start date
2020-06-04
Primary completion
2030-05-01
Completion
2030-05-01
First posted
2020-12-31
Last updated
2025-05-28

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04690660. Inclusion in this directory is not an endorsement.